Latest News

In today’s rapidly evolving cryptocurrency landscape, cloud mining is transforming how people build their digital wealth—removing the traditional barriers of mining complexity. As a trusted industry leader, Oak Mining offers a secure and user-friendly platform for mining popular cryptocurrencies such as Bitcoin and Dogecoin. Built with simplicity in mind, we ensure transparent pricing and reliable [...]

Prop trading gives traders access to a firm’s capital instead of relying on their own funds. The arrangement is simple: the trader generates profits in the market, and those profits are shared between the firm and the trader based on a predefined split. These programs cover a wide mix of markets, including forex, indices, stocks, [...]

You might not see it, but it can be costly for companies not to take it seriously.

One investor is making a bold bet on Amylyx just as its 2026 catalyst calendar starts to take shape.

ASML serves a foundational role in advancing AI.

This investor just walked away as Scholar Rock heads into a pivotal 2026—here’s what that means for long-term shareholders.

There is more to this news than meets the eye.

You can still grow your money after taking out an RMD.

Speaking during The New York Times DealBook Summit 2025, Bessent acknowledged that his views on tariffs have evolved since 2024.

One fast-rising biotech just landed a heavyweight backer ahead of a pivotal presentation—here’s what investors should watch.

OPEC’s exports account for nearly 50% of all the world’s crude exports, and the organization and its allies hold almost 80% of the world’s oil reserves.

Pharvaris stock surged Wednesday on promising test results for an HAE drug.

The HOPE-3 study, involving 106 participants across 20 U.S. centres, delivered strong signals of benefit for muscle and heart function.

A few days of massive gains may not be enough to rescue this stock long term.